GleamWall
中文EN

TNXP Tonix Pharmaceuticals Holding Corp.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1430306 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY318.0%
TTM net income YoY-82.4%
TTM EPS YoY-104.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin89.3%
Operating margin-436.3%
Net margin-420.4%
FCF margin-395.0%
EBITDA margin-431.0%

Returns

ROE-84.1%
ROA-73.1%
ROIC (approx.)-387.9%
Asset turnover0.17x

Leverage & solvency

Liabilities / assets17.7%
Debt / equity0.00x
Current ratio4.57x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.91x
Accruals ratio-6.3%
Payout ratio—
Capex / revenue11.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$13.11M$10.09M
Cost of revenue$6.64M$7.76M
Gross profit$6.47M$2.33M
R&D expense$44.49M$39.97M
SG&A expense$87.68M$40.10M
Operating income-$125.70M-$136.70M
Interest expense$89,000$1.23M
Pretax income-$34.03M-$80.59M
Net income-$124.02M-$130.04M
EBITDA-$123.78M-$133.28M
EPS (basic)-14.57-176.60
EPS (diluted)-14.57-176.60
Weighted avg. shares (diluted)8.51M736,339
Balance sheet
Cash & equivalents$207.64M$99.68M
Receivables$6.27M$3.68M
Inventory—$8.41M
Current assets$228.88M$119.00M
PP&E, net$44.46M$42.25M
Intangibles$120,000$120,000
Total assets$277.17M$162.89M
Current liabilities$30.84M$18.31M
Short-term debt—$2.82M
Long-term debt—$4.67M
Total debt—$7.49M
Total liabilities$32.02M$23.33M
Shareholders' equity$245.15M$139.56M
Net debt—-$92.19M
Shares outstanding12.79M4.39M
Cash flow statement
Operating cash flow-$99.84M-$60.92M
Capital expenditure$3.37M$120,000
Free cash flow-$103.21M-$61.05M
Investing cash flow-$4.53M-$120,000
Financing cash flow$214.53M$134.87M
Depreciation & amortization$1.93M$3.42M
Stock-based compensation$6.02M$4.78M
Share buybacks$13.76M—

Free plan shows the latest 2 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.